Patients with overweight or obesity were more likely to have HER2- disease, and tumors of No Special Type (formerly known as ductal carcinoma) compared with patients with normal weight (Table 2). Here, ERBB2 is linked to obesity due to melanocortin 4 receptor deficiency.